| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |